Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.21.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Class A Common Stock
Common Stock
Class B Common Stock
Common Stock
Beginning balance (in shares) at Sep. 30, 2019             32,597,736 22,106,961
Beginning balance at Sep. 30, 2019 $ 343,550 $ (222) $ 243,452 $ (15,603) $ 115,646 $ (222) $ 33 $ 22
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 5,461       5,461      
Equity-based compensation expense $ 395   395          
Conversion of Class B common stock to Class A common stock (in shares)             107,682 (107,682)
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201602Member              
Ending balance (in shares) at Dec. 31, 2019             32,705,418 21,999,279
Ending balance at Dec. 31, 2019 $ 349,184   243,847 (15,603) 120,885   $ 33 $ 22
Beginning balance (in shares) at Sep. 30, 2019             32,597,736 22,106,961
Beginning balance at Sep. 30, 2019 343,550 $ (222) 243,452 (15,603) 115,646 $ (222) $ 33 $ 22
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 6,998              
Ending balance (in shares) at Mar. 31, 2020             32,705,418 21,999,279
Ending balance at Mar. 31, 2020 351,111   244,237 (15,603) 122,422   $ 33 $ 22
Beginning balance (in shares) at Dec. 31, 2019             32,705,418 21,999,279
Beginning balance at Dec. 31, 2019 349,184   243,847 (15,603) 120,885   $ 33 $ 22
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 1,537       1,537      
Equity-based compensation expense 390   390          
Ending balance (in shares) at Mar. 31, 2020             32,705,418 21,999,279
Ending balance at Mar. 31, 2020 351,111   244,237 (15,603) 122,422   $ 33 $ 22
Beginning balance (in shares) at Sep. 30, 2020             33,875,884 20,828,813
Beginning balance at Sep. 30, 2020 385,195   245,022 (15,603) 155,721   $ 34 $ 21
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 7,871       7,871      
Equity-based compensation expense 395   395          
Ending balance (in shares) at Dec. 31, 2020             33,875,884 20,828,813
Ending balance at Dec. 31, 2020 393,461   245,417 (15,603) 163,592   $ 34 $ 21
Beginning balance (in shares) at Sep. 30, 2020             33,875,884 20,828,813
Beginning balance at Sep. 30, 2020 385,195   245,022 (15,603) 155,721   $ 34 $ 21
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 2,936              
Ending balance (in shares) at Mar. 31, 2021             35,719,569 19,495,861
Ending balance at Mar. 31, 2021 388,986   245,877 (15,603) 158,657   $ 35 $ 20
Beginning balance (in shares) at Dec. 31, 2020             33,875,884 20,828,813
Beginning balance at Dec. 31, 2020 393,461   245,417 (15,603) 163,592   $ 34 $ 21
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (4,935)       (4,935)      
Equity-based compensation expense 460   460          
Issuance of stock grant awards (in shares)             510,733  
Conversion of Class B common stock to Class A common stock (in shares)             1,332,952 (1,332,952)
Conversion of Class B common stock to Class A common stock 0           $ 1 $ (1)
Ending balance (in shares) at Mar. 31, 2021             35,719,569 19,495,861
Ending balance at Mar. 31, 2021 $ 388,986   $ 245,877 $ (15,603) $ 158,657   $ 35 $ 20